161 Fort Washington AveNew York, NY 10032
Overview of Dr. Fojo
Dr. Antonio Fojo is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 49 years. He is one of 123 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 398 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1978 - 1982
University of Miami Leonard M. Miller School of MedicineClass of 1977
Certifications & Licensure
NY State Medical License 2015 - 2027
MD State Medical License 1983 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2016
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016
Clinical Trials
- LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) Start of enrollment: 2019 Jun 17
Roles: Sponsor-Investigator, Principal Investigator, Contact
- Entinostat Neuroendocrine (NE) Tumor Start of enrollment: 2017 Dec 13
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colore...Mark J Ratain, Antonio Tito Fojo
Journal of Clinical Oncology. 2026-01-10 - 1 citationsDocetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer.Pedro C Barata, June K Corrigan, Jennifer La, John M Culnan, Elliot Akama-Garren
JAMA Network Open. 2026-01-02 - Cancer interception during treatment: using growth kinetics to create a continuous variable for assessing disease response.Mengxi Zhou, Antonio T Fojo, Lawrence H Schwartz, Susan E Bates, Krastan B Blagoev
The Oncologist. 2025-11-11
Grant Support
- Creating precision in metastatic hormone sensitive prostate cancer: Using tumor genetics and patient characteristics to predict outcomes and improve treatment selectionST. LOUIS VA MEDICAL CENTER2025–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
